A Study of Prevalence of HPV and Determinants of Poor Outcomes of HIV Positive and Negative Patients with Oropharyngeal Cancers in Botswana

Kathryn Anastos

HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium

Other pharynx Lip, oral cavity

Pathology

Nathaniel Rothman

Studies in the Janus Cohort

Lip, oral cavity

Pathology

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Lip, oral cavity

Pathology

Maureen Joffe

HIVs Effects on Breast Cancer Treatment and Outcomes in South Africa

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri Breast

Jeffrey Nicholas Myers

Predicting and overcoming chemoradioresistance in p53-mutant head and neck cancer

Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx

Julio A Aguirre-Ghiso

Functional Determinants of Metastatic Dormancy

Other pharynx Nasopharynx

Pathology

Robert W. Coombs

Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri

Zhen Fan

A novel targeted therapy for HNSCC based on a novel activity of cetuximab

Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx